SEC 13F Intelligence

Syquant Capital Sas / CELG

Syquant Capital Sas’s Celgene Corp Position

Does Syquant Capital Sas own Celgene Corp (CELG)? Not currently — the last reported position was 619.7K shares worth $62M in Q3 2019; the fund’s latest 13F (Q2 2026) no longer reports it.

Position Value
$62M
Q3 2019
Shares
619.7K
% of Portfolio
+16.85%
Quarters Held
2
position exited

Position History CELG

Reported value by quarter
Q2 ’19: $35MQ2 ’19Q3 ’19: $62MQ3 ’19filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2019619.7K$62M+16.85%
Q2 2019379.9K$35M+11.27%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Syquant Capital Sas’s full portfolio or all institutional holders of CELG.